Stuart Sedlack serves as Vice President, Business Development. He has over 20 years of experience in the pharmaceutical industry, leading corporate business development and closing numerous transactions. Prior to Sebela Pharmaceuticals, Mr. Sedlack was SVP, Corporate Development at Velocity Pharmaceutical Development, Amarin Pharma and Alba Therapeutics, serving as a member of the executive team at each company. Mr. Sedlack also headed transaction negotiations for Novartis Pharma’s infectious disease franchise and was VP, Corporate Development at Elan Corporation after serving as Director at the University of Maryland Medical System’s tech transfer office. Before entering the pharma industry, Mr. Sedlack spent five years in international trade banking. Mr. Sedlack holds a B.S. in Economics from the University of Richmond and a MBA from Babson College.

 Stuart Sedlack serves as Vice President, Business Development. He has over 20 years of experience in the pharmaceutical industry, leading corporate business development and closing numerous transactions. Prior to Sebela Pharmaceuticals, Mr. Sedlack was SVP, Corporate Development at Velocity Pharmaceutical Development, Amarin Pharma and Alba Therapeutics, serving as a member of the executive team at each company. Mr. Sedlack also headed transaction negotiations for Novartis Pharma’s infectious disease franchise and was VP, Corporate Development at Elan Corporation after serving as Director at the University of Maryland Medical System’s tech transfer office. Before entering the pharma industry, Mr. Sedlack spent five years in international trade banking. Mr. Sedlack holds a B.S. in Economics from the University of Richmond and a MBA from Babson College.